The investors below the stage gathered in twos and threes to chat. Some of them exchanged words like Young and Wang Hongbo, while others chatted like friends about things unrelated to work.
Lei Jun, wearing the same blue shirt he has worn countless times in public, stepped onto the stage to give his speech.
"Welcome everyone to the sharing session of Kechuang Biotechnology. As one of the shareholders of Kechuang Biotechnology, I'd like to start by warming up the atmosphere for Zheng Li."
"We do have something to share with you all, but there's another aspect to this meeting: we're looking to secure a second round of investment."
“When I was chatting with Zheng Li in private, I said that I would just invest all of the second round of investment in you. Just tell me how much you want, and I will cover it all.”
"Then Zheng Li took out a document for me to see, which is the document that I am going to share with you all today. After reading it, I was silent because it was too expensive and I couldn't afford it."
After Lei Jun finished speaking, the investors in the audience exchanged glances. If Lei Jun couldn't afford it, how high would the valuation for the second round of investment be?
"Moreover, from another perspective, a company is more likely to grow if it has more investors."
"After all, I have always worked primarily in the internet industry, so the only thing I can offer in the biopharmaceutical industry is funding."
“A successful company cannot grow on its own; we need more investors to support its growth.”
“We have sent out invitations to everyone. Since you are all willing to attend the sharing session on Kechuang Biotechnology, I would presume that you have the intention to invest.”
"Many of the people in the audience are familiar faces, such as IDG, Qiming Venture Partners and Morningside Venture Capital. These investment institutions all participated in the Series A funding of Dami. At that time, I was running around meeting with investors everywhere, and the Series A funding only raised $41 million."
“When Zheng Li contacted me, he said he was a fan of mine and wanted to chat with me. I thought to myself that I was a little proud to have a fan who published a Nature paper at the age of 18, plus the fact that we were senior and junior students.”
“I talked to him for a bit, and things went wrong. He took 50 million from me in half an hour on the phone, but the unit was RMB.”
"I even wanted to give him more money."
“Liu Qin from Morningside Venture Capital and I are old acquaintances. Morningside Venture Capital previously only invested in Internet companies. Not long ago, Liu Qin asked me when your second round of investment in Kechuang Bio would begin?”
"Could we also place some bets?"
"In addition, so many investors have recently contacted me about this, all asking if I need money. Phase II and III clinical trials definitely require funding, and clinical trials in Europe and the United States are even more expensive. Do you need us to invest some money in you?"
"This is a happy problem. Investors are rushing to give me money, which reminds me of the days when I invested in Damila. It still makes me feel a little sad. The senior is not as good as the junior."
"Getting back to the main point, after today's sharing session, everyone's desire to invest in science and technology innovation and biotechnology will definitely be even stronger."
"Now let's welcome Zheng Li, Chairman of Kechuang Biotechnology, to share the company's latest developments with everyone."
At 3:35 PM, Zheng Li waited for five minutes before walking onto the stage:
"Mr. Lei spoke very well. I can see that everyone in the audience is listening with great interest. My speech may be much more boring."
Having spent almost a year on Earth, Zheng Li can now use idioms and similar expressions with ease.
"I'm sure everyone has a general understanding of endorphins. Today, I'll mainly introduce some things that you might not know."
"Firstly, the synthesis cost of endorphins via industrial synthesis is at most 20% higher than that of morphine, but their analgesic efficacy is ten times that of morphine."
"However, endorphins are far more addictive than morphine and any opioid painkillers."
If only analgesic effects are considered, fentanyl is 50-100 times more effective than morphine. Moreover, the synthesis cost of fentanyl is almost the same as that of morphine.
But this stuff is extremely addictive, no less so than heroin.
"Simply put, moderate use of endorphins will not cause addiction, which is good news for all cancer patients."
"In addition, I have recently made a major discovery: injecting endorphins and lipoprotein trypsin peptides in a certain dosage ratio can effectively reduce patients' dependence on opioids after one course of treatment."
"Including opioids such as heroin."
As soon as he finished speaking, the investors in the audience erupted in cheers. This was an epic discovery. If it were true, Zheng Li would be more than qualified to win the Nobel Prize for it.
It's important to know that countless scientists from academia and industry have made attempts to reduce addiction over the years.
Scientists have tried countless methods, both in terms of drugs and cognitive behavior, but have not found a good solution.
More importantly, this means there is hope for curing or alleviating drug addiction. This market is incredibly vast and is essentially a monopoly.
Zheng Li saw that almost everyone in the audience had raised their hands, their faces full of questions. He gestured and said, "Please have the staff hand the microphone to the lady at the very front of the audience."
The lady at the front was Stephanie from Goldman Sachs, and she got straight to the point:
"Mr. Zheng, hello. I'm sorry my question might have offended you a little. Please apologize in advance."
"But I believe these are also the questions of all the investors present."
"How much can endorphins combined with another medication, taken as part of a course of treatment, effectively reduce a patient's addiction to opioids?"
Zheng Li replied, "We have achieved a complete cure in mice. As long as they are no longer exposed to opioids, they will not become dependent on them."
Stephanie looked at him in disbelief: "Are you serious?"
Zheng Li solemnly replied, "Absolutely true!"
Stephanie: "I'm sorry this news is so shocking. I thank you on behalf of countless addicts."
"But I still have to ask, Kechuang Bio is about to undergo its second round of venture capital, and now you are revealing such unprecedented good news to us. I have some doubts about its authenticity."
“None of us want a repeat of Holmes’s case. Holmes’s company claimed to be able to detect cancer with a drop of blood, but it turned out that the effects she claimed were simply impossible to achieve.”
Stephanie was worried that Zheng Li was too young to know who Elizabeth Holmes was.
"I don't doubt you, I just want to confirm the authenticity of your message."
Zheng Li nodded and said, "I understand your concerns. I have already written down the experimental process and conclusions in a paper and submitted it to The Lancet regarding this discovery."
"After receiving the endorphins and lipoprotein trypsin peptides that I sent, the editors of The Lancet successfully reproduced the experiment and its results on mice."
"The paper will be featured on the cover of the latest issue of The Lancet, and you can also contact a laboratory you trust to reproduce the experimental procedures described in it."
Continue read on readnovelmtl.com
